Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

174.52
Delayed Data
As of 4:00pm ET
 -1.48 / -0.84%
Today’s Change
151.80
Today|||52-Week Range
195.81
+5.32%
Year-to-Date

Today’s Trading

Previous close176.00
Today’s open176.01
Day’s range171.96 - 176.50
Volume1,149,574
Average volume (3 months)1,155,154
Market cap$44.9B
Data as of 4:00pm ET, 09/18/2019

Growth & Valuation

Earnings growth (last year)+677.36%
Earnings growth (this year)+12.58%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+22.51%
P/E ratio20.4
Price/Sales14.09
Price/Book10.05

Competitors

 Today’s
change
Today’s
% change
TAKTakeda Pharmaceutica...-0.20-1.15%
AGNAllergan-0.11-0.07%
----
ZTSZoetis Inc+0.86+0.70%
Data as of 4:00pm ET, 09/18/2019

Financials

Next reporting dateOctober 23, 2019
EPS forecast (this quarter)$1.13
Annual revenue (last year)$3.0B
Annual profit (last year)$2.1B
Net profit margin68.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
Chief Financial Officer &
Executive Vice President
Charles F. Wagner
Corporate headquarters
Boston, Massachusetts

Forecasts